Placement Agent Warrants. The Company agreed to issue to the Placement Agent or its designee(s) that number of warrants equal to three percent (3%) of the aggregate number of shares of Common Stock and Pre-Funded Warrants sold in the Offering in the form of Exhibit A attached hereto (“Placement Agent Warrants”).
Appears in 2 contracts
Sources: Placement Agency Agreement (bioAffinity Technologies, Inc.), Placement Agency Agreement (bioAffinity Technologies, Inc.)
Placement Agent Warrants. The Company agreed to issue to the Placement Agent or its designee(s) that number of warrants equal to three percent (3%) of the aggregate number of shares securities of Common Stock and Pre-Funded Warrants common stock sold in the Offering in the form of Exhibit A attached hereto (“Placement Agent Warrants”).
Appears in 2 contracts
Sources: Placement Agency Agreement (bioAffinity Technologies, Inc.), Placement Agency Agreement (bioAffinity Technologies, Inc.)
Placement Agent Warrants. The Company agreed to issue to the Placement Agent or its designee(s) that number of warrants equal to three percent (3%) of the aggregate number of shares of Common Stock and Pre-Funded Warrants Conversion Shares sold in the Offering in the form of Exhibit A attached hereto (“Placement Agent Warrants”).
Appears in 1 contract
Sources: Placement Agency Agreement (bioAffinity Technologies, Inc.)
Placement Agent Warrants. The Company agreed to issue to the Placement Agent or its designee(s) that number of warrants equal to three four percent (34%) of the aggregate number of shares securities of Common Stock and Pre-Funded Warrants common stock sold in the Offering in the form of Exhibit A attached hereto (“Placement Agent Warrants”).
Appears in 1 contract
Sources: Placement Agency Agreement (BullFrog AI Holdings, Inc.)
Placement Agent Warrants. The Company agreed to issue to the Placement Agent or its designee(s) that number of warrants equal to three two percent (32%) of the aggregate number of shares securities of Common Stock and Pre-Funded Warrants common stock sold in the Offering in the form of Exhibit A attached hereto (“Placement Agent Warrants”).
Appears in 1 contract
Sources: Placement Agency Agreement (bioAffinity Technologies, Inc.)